FdaApplication
ANDA 203769
Identifiers
- fda_app_no: ANDA203769
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2013-09-11 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | 1GM | TABLET;ORAL |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | 750MG | TABLET;ORAL |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | 850MG | TABLET;ORAL |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | 625MG | TABLET;ORAL |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | 500MG | TABLET;ORAL |
5 products